EDU 04 - (INTERACTIVE) Management of the Axilla and Neoadjuvant Systemic Therapy
4:45 PM - 6:15 PM
Location: Room 214 A/B
Session Type: Educational
1.50 AMA PRA Category 1 Credits™
1.50 CAMPEP Credits
1.50 MDCB Credits
In this session, presenters will discuss the controversies involved in radiotherapy and surgical decision-making in the era of neoadjuvant systemic therapy. Data from randomized trials will be described where available, along with the relevant strengths and limitations. Supplemental data describing factors that modify risk of recurrence and potential radiotherapy impact will also be reviewed, as will ongoing trials that may impact management of this clinical scenario in coming years. Data characterizing the relationship between chemotherapy response and locoregional control will also be reviewed, as will impact on patient long-term morbidity and quality of life. Again, priority will be given to data from randomized and/or prospective trials but other robust series will also be incorporated. The instructors will incorporate case presentations designed to illustrate salient points from the didactic presentations as appropriate.
- Demonstrate knowledge of relevant, including ongoing, clinical trials and supplemental data impacting the management of patients with radiation following neoadjuvant systemic therapy.
- Determine relevant indications for radiation among patients receiving neoadjuvant chemotherapy, including consideration of ongoing clinical trials as appropriate.
- Make decisions regarding axillary management of the axilla following receipt of neoadjuvant systemic therapy and its impact on radiotherapy decision-making, incorporating impact of patient quality-of-life.
4:45 PM - 5:10 PM
Axillary surgery considerations in the era of neoadjuvant systemic therapy
5:10 PM - 5:35 PM
Radiation Considerations in the Era of Neoadjuvant Systemic Therapy
5:35 PM - 6:00 PM
Lymphedema and other Quality-Of-Life Considerations after Neoadjuvant Systemic Therapy
6:00 PM - 6:15 PM